Pyxis Oncology, Inc. (PYXS) Total liabilities 2024–2025
Pyxis Oncology, Inc. (PYXS) total liabilities at each fiscal year-end, per SEC filings.
$38.1MFY2025 · since FY2024: $36.4M → $38.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $38.1M | +4.6% |
| FY2024 | $36.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating incomePYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Shareholders’ equityPYXS overview →